ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatmen...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
Pathogenesis of colon adenocarcinoma in Kerala, India
Dr Prasanth Ariyannur - Amrita Institute of Medical Sciences and Research Center...
ESMO 2021: Latest in EGFR mutated advanced NSCLC
Dr Anna Minchom, Prof Natasha Leighl, Dr Victor Moreno and Dr Carlos Cabrera
First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and br...
Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA
Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastati...
Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain
ESMO 2021: PARPi data and their role in mono/combination therapies
Dr Neal Shore, Prof Fred Saad, Prof Eleni Efstathiou, Prof Andrew Armstrong
Radioembolisation with chemotherapy for colorectal liver metastases
Dr Mary Mulcahy - Northwestern Memorial Hospital, Chicago, USA
ESMO 2021: Breast cancer roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally a...
Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain
Enzalutamide plus androgen deprivation therapy prolongs survival in men with met...
Prof Andrew Armstrong - Duke University, Durham, USA
Advances in prostate cancer in the last 10 years and a glimpse to the future
Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono
Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve ef...
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK